Could digestive enzymes soothe stomach pain?
NCT ID NCT07578402
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding digestive enzymes to standard treatment helps people with functional dyspepsia, a condition causing stomach fullness, pain, and burning. 120 adults will take either enzymes plus standard care or standard care alone for 4 weeks. Researchers will track symptom changes and any side effects.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- digestive enzymes
- What this could lead to
- If it works, this could offer a simple, safe add-on to ease uncomfortable digestive symptoms for people with functional dyspepsia.
- What could go wrong
- This is a small, early-phase trial with only 120 participants. The results may not apply to everyone, and digestive enzymes might not provide extra benefit over standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
About 120 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Feb 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18 years or more * Patients with FD diagnosed according to ROME IV criteria Exclusion Criteria: * Structural lesion in endoscopy and positive H. pylori status * History of malignancy, liver and biliary tract disease, diabetes mellitus, chronic kidney disease, thyroid disorders * Psychiatric disorders * Previous history gastrointestinal surgery * Any history of hypersensitivity, adverse effect, or ineffectiveness with digestive enzyme * Pregnancy and breastfeeding.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dyspepsia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Dhaka Medical College
Dhaka, 1000, Bangladesh
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ear zaps and stomach maps: a new way to read a misbehaving gut
- Can a website teach patients to tame gut pain and skip needless hospital tests?
- Could a routine blood count reveal hidden stomach infection?
- Can a capsule calm the Post-Meal stomach blues?
- Can a natural supplement soothe an upset stomach?
- Can a Two-Drug combo beat acid suppression alone for stomach discomfort?